59.24
Finanzdaten der Ptc Therapeutics Inc-Aktie (PTCT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
32.28%
360.52
|
272.55 | 164.68 | 211.01 | 178.88 |
|
|
7.05%
211.54
|
227.59 | 236.03 | 207.99 | 213.83 |
| Operating Income/Loss |
231.36%
148.98
|
44.96 | -71.35 | 3.016 | -34.96 |
| Income/Loss From Continuing Operations Before Tax |
4,062%
97.55
|
-2.462 | -139.08 | -23.07 | -71.05 |
| Income Tax Expense/Benefit |
3,949%
14.05
|
0.347 | -4.118 | -38.97 | -6.203 |
|
|
3,072%
83.50
|
-2.809 | -134.97 | 15.90 | -64.85 |
| Basic Average Shares |
0.59%
83.01
|
82.52 | 0.8918 | 78.47 | 78.15 |
| Diluted Average Shares |
11.51%
92.02
|
82.52 | 1.4118 | 87.12 | 78.15 |
| Basic Earnings Per Share |
3,467%
1.01
|
-0.03 | -1.82 | 0.20 | -0.83 |
| Diluted Earnings Per Share |
3,167%
0.92
|
-0.03 | -1.67 | 0.20 | -0.83 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):